Photodynamic Therapy (PDT) for Poor Prognosis Recurrent/Refractory Malignant Brain Tumors - A Phase I Study
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Brain cancer
- Focus Adverse reactions
- 02 Dec 2016 Status changed from active, no longer recruiting to recruiting.
- 31 May 2016 Planned End Date changed from 1 Apr 2021 to 1 Apr 2024.
- 31 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2019.